Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Mesa LaboratoriesMLAB +0.07%75 Intrinsic Value: Projected FCF is $99.25 as of Aug. 29, 2026. GuruFocus rates MLAB with a GF Score™ of 75/100 and a GF Value™ of $106.26 (Modestly Overvalued). The stock has 9 warning signs investors should review. Among 1,692 Hardware companies, Mesa Laboratories ranks better than 60.22% on this metric.
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.
As of today (2026-08-29), Mesa Laboratories's Intrinsic Value: Projected FCF is $99.25. The stock price of Mesa Laboratories is $128.88. Therefore, Mesa Laboratories's Price-to-Intrinsic-Value-Projected-FCF of today is 1.3.
The historical rank and industry rank for Mesa Laboratories's Intrinsic Value: Projected FCF or its related term are showing as below:
MLAB'
s Price-to-Projected-FCF Range Over the Past 10 Years
Min: 0.69 Med: 2.22 Max: 3.89
Current: 1.29
During the past 13 years, the highest Price-to-Intrinsic-Value-Projected-FCF of Mesa Laboratories was 3.89. The lowest was 0.69. And the median was 2.22.
MLAB's Price-to-Projected-FCF is ranked better than 60.22% of 1692
companies
in the Hardware industry
Industry Median: 1.725
vs MLAB: 1.29
The growth multiple is capped between 8.35 and 17.74.
Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.
Mesa Laboratories's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as
Price-to-Intrinsic-Value-Projected-FCF
=
Share Price
/
Intrinsic Value: Projected FCF
=
128.88
/
99.253512796114
=
1.30
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mesa Laboratories Intrinsic Value: Projected FCF Related Terms
Mesa Laboratories Intrinsic Value: Projected FCF Historical Data
* Premium members only.
The historical data trend for Mesa Laboratories's Intrinsic Value: Projected FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MLAB vs AERG, USBC, WRAP: Intrinsic Value: Projected FCF Comparison
For the Scientific & Technical Instruments subindustry, Mesa Laboratories's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mesa Laboratories Price-to-Projected-FCF vs Hardware Industry
For the Hardware industry and Technology sector, Mesa Laboratories's Price-to-Projected-FCF distribution charts can be found below:
* The bar in red indicates where Mesa Laboratories's Price-to-Projected-FCF falls into.
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.
The details of how we calculate the intrinsic value of stocks are described in detail here.
This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Intrinsic Value: Projected FCF of $99.25 mean?
Mesa Laboratories (MLAB) has a Intrinsic Value: Projected FCF of $99.25 as of Aug. 29, 2026. Intrinsic Value: Projected FCF is the stock value based on a projected free cash flow model. View historical data on Mesa Laboratories and its competitors. According to the industry distribution chart, Mesa Laboratories ranks #673 out of 1692 companies in the Hardware industry, placing it in the top 39.8%.
Is Mesa Laboratories' Intrinsic Value: Projected FCF too high?
Mesa Laboratories' current Intrinsic Value: Projected FCF is $99.25. The Hardware industry median Intrinsic Value: Projected FCF is 1.73. Mesa Laboratories' value of $99.25 is 5653.6% above this industry median. Based on the distribution chart, Mesa Laboratories ranks #673 out of 1692 companies in the Hardware industry, which is above the industry midpoint. Overall, Mesa Laboratories has a GF Score™ of 75/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Mesa Laboratories' Intrinsic Value: Projected FCF compare to AERG and USBC?
According to the Hardware industry distribution chart, Mesa Laboratories ranks #673 out of 1692 companies for Intrinsic Value: Projected FCF. This puts Mesa Laboratories in the upper half of its industry. The industry median Intrinsic Value: Projected FCF is 1.73. Mesa Laboratories' value of $99.25 is 5653.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Intrinsic Value: Projected FCF for a Hardware company?
The median Intrinsic Value: Projected FCF among Hardware companies is 1.73, based on 1,692 companies in the industry. Companies in the top quartile (top 25%) have a Intrinsic Value: Projected FCF significantly above this median, while those in the bottom quartile fall well below. However, Intrinsic Value: Projected FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mesa Laboratories's current Intrinsic Value: Projected FCF of $99.25 is 5653.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Intrinsic Value: Projected FCF mean?
A high Intrinsic Value: Projected FCF can signal that a stock is expensive relative to its fundamentals. Intrinsic Value: Projected FCF is the stock value based on a projected free cash flow model. View historical data on Mesa Laboratories and its competitors. For the Hardware industry, the median Intrinsic Value: Projected FCF is 1.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mesa Laboratories's current Intrinsic Value: Projected FCF is $99.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mesa Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Mesa Laboratories (MLAB) is currently considered Modestly Overvalued. The stock's GF Value™ is $106.26, compared to a current price of $128.88 — trading 21.3% above its estimated fair value. The current Intrinsic Value: Projected FCF is $99.25 and 5653.6% above the Hardware industry median of 1.73. Mesa Laboratories' overall GF Score™ is 75/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Intrinsic Value: Projected FCF calculated?
Intrinsic Value: Projected FCF is calculated from a company's financial statements. For Mesa Laboratories (MLAB), the current Intrinsic Value: Projected FCF is $99.25 as of Aug. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mesa Laboratories (MLAB) Overvalued in 2026?
Based on GuruFocus' analysis, Mesa Laboratories stock appears to be overvalued.
The current stock price of $128.88 is trading 21.3% above its estimated GF Value™ of $106.26.
GuruFocus considers Mesa Laboratories to be Modestly Overvalued.
Key valuation signals for MLAB:
Intrinsic Value: Projected FCF: $99.25
GF Value™: $106.26 vs. price of $128.88 (21.3% above fair value)
Industry Position: 5653.6% above the Hardware median (#673 of 1692)
No single metric tells the full story. See the MLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.
75GF Score
Get the complete analysis for MLAB
Intrinsic Value: Projected FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MLAB has been successfully added to your 
